The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer

Introduction: 5-alpha reductase inhibitors can reduce the risk of prostate cancer (PCa) but can be associated with significant side effects. A library of nomograms which predict the risk of clinical endpoints relevant to dutasteride treatment may help determine if chemoprevention is suited to the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Carvell T., Isariyawongse, Brandon, Yu, Changhong, Kattan, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468831/
https://www.ncbi.nlm.nih.gov/pubmed/23087901
http://dx.doi.org/10.3389/fonc.2012.00138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468831/
https://www.ncbi.nlm.nih.gov/pubmed/23087901
http://dx.doi.org/10.3389/fonc.2012.00138

Ejemplares similares